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Introduction
Declining rates in the incidence of colorectal can-
cer (CRC) in the past decade have been attrib-
uted to the upsurge in CRC screening, particularly 
with the use of colonoscopy [Edwards et al. 2010]. 
Nationally, 64.7% of Americans in 2010 reported 
having ever had an endoscopic exam as screening 
for CRC [Centers for Disease Control and 
Prevention, 2011]. Reports indicate, however, 
that as many as 30% of precolonoscopy bowel 
preparations are not optimal [Kazarian et al. 
2008]. As progressively more Americans screen 
Split dose and MiraLAX-based purgatives 
to enhance bowel preparation quality 
becoming common recommendations  
in the US
Grace Clarke Hillyer, Benjamin Lebwohl, Corey H. Basch, Charles E. Basch, Fay Kastrinos, 
Beverly J. Insel and Alfred I. Neugut 
Abstract:  
Objectives: Rates of suboptimal bowel preparation up to 30% have been reported. Liberalized 
precolonoscopy diet, split dose purgative, and the use of MiraLAX-based bowel preparation 
(MBBP) prior to colonoscopy are recently developed measures to improve bowel preparation 
quality but little is known about the utilization prevalence of these measures. We examined 
the patterns of utilization of these newer approaches to improve precolonoscopy bowel 
preparation quality among American gastroenterologists.
Methods: Surveys were distributed to a random sample of members of the American 
College of Gastroenterologists. Participants were queried regarding demographics, practice 
characteristics, and bowel preparation recommendations including recommendations for 
liberal dietary restrictions, split dose purgative, and the use of MBBP. Approaches were 
evaluated individually and in combination.
Results: Of the 999 eligible participants, 288 responded; 15.2% recommended a liberal diet, 
60.0% split dose purgative, and 37.4% MBBP. Diet recommendations varied geographically 
with gastroenterologists in the West more likely to recommend a restrictive diet (odds ratio 
[OR] 2.98, 95% confidence interval [CI] 1.16–7.67)  and physicians in the Northeast more 
likely to recommend a liberal diet more likely. Older physicians more often recommended 
split dosing (OR 1.04, 95% CI 1.04–2.97). Use of MBBP was more common in suburban 
settings (OR 2.14, 95% CI 1.23–3.73). Evidence suggests that physicians in private practice 
were more likely to prescribe split dosing (p = 0.03) and less often recommended MBBP 
(p = 0.02). Likelihood of prescribing MBBP increased as weekly volume of colonoscopy 
increased (p = 0.03).
Conclusions: To enhance bowel preparation quality American gastroenterologists commonly 
use purgative split dosing. The use of MBBP is becoming more prevalent while a liberalized 
diet is infrequently recommended. Utilization of these newer approaches to improve bowel 
preparation quality varies by physician and practice characteristics. Further evaluation of the 
patterns of usage of these measures is indicated.
Keywords: bowel preparation, colonoscopy, liberal diet, MiraLAX, split dose purgative
Correspondence to: 
Grace Clarke Hillyer, EdD, 
MPH 
Associate Research 
Scientist, Department of 
Epidemiology, Mailman 
School of Public Health, 
Columbia University, 722 
West 168th Street, New 
York, NY 10032, USA 
gah28@columbia.edu
Benjamin Lebwohl, MD 
Fay Kastrinos, MD 
College of Physicians and 
Surgeons of Columbia 
University - Division 
of Digestive and Liver 
Diseases, New York, 
New York USA
Corey H. Basch, EdD, MPH  
Department of Public 
Health, William Paterson 
University, Wayne, NJ, USA
Charles E. Basch, PhD  
Herbert Irving 
Comprehensive Cancer 
Center, College of 
Physicians and Surgeons 
of Columbia University, 
New York, NY, USA
Beverly J. Insel, DrPH  
Department of 
Epidemiology, Mailman 
School of Public Health, 
Columbia University, 
New York, NY, USA
Alfred I. Neugut, MD, PhD 
College of Physicians and 
Surgeons of Columbia 
University - Division of 
Hematology and Oncology, 
New York, New York, USA
464100 TAG611756283X12464100Therapeutic Advances in GastroenterologyGC Hillyer, B Lebwohl
2012
Therapeutic Advances in Gastroenterology 6 (1)
6 http://tag.sagepub.com
for CRC with colonoscopy, bowel preparation 
quality becomes increasingly important. Poor 
bowel preparation not only impacts the quality 
and completeness of the endoscopic examination, 
but can inflate the cost of screening, require 
longer inspection time, and result in repeat proce-
dure [Ben-Horin et al. 2007; Froehlich et al. 
2005; Rex et al. 2002]. Most importantly, poorly 
prepared bowels that limit the endoscopist’s abil-
ity to visualize the colonic mucosa are associated 
with lower adenoma detection rates and missed 
neoplasia [Lebwohl et al. 2011; Rex et al. 2002].
The combined use of cathartics and dietary 
restrictions is safe and effective for bowel prepara-
tion prior to colonoscopy but there exists no con-
sensus regarding which preparation results in 
optimal bowel cleansing [Parra-Blanco, 2006], 
thus regimens vary widely [DiPalma et al. 1984]. 
The predominant method of bowel preparation in 
use today is oral gastrointestinal (GI) lavage using 
balanced electrolyte solutions with polyethylene 
glycol (PEG) [A-Rahim and Falchuk, 2011]. 
Evidence suggests that a clear liquid diet prior to 
the purgative and colonoscopy is a beneficial 
adjunct to bowel cleansing methods [Wexner 
et al. 2006]; however, patients complain about the 
large volume of purgative that needs to be ingested 
with many regimens and the requirement for a 
clear liquid diet [Hookey et al. 2004]. In addition, 
ingestion of the purgative has been often cited as 
the most unpleasant part of the colonoscopy 
experience for many patients [Ko et al. 2007].
In order to increase patient tolerability, minimize 
side effects, and improve cleansing efficacy of 
preparations, newer methods of bowel prepara-
tion have been developed and include the use of 
laxative supplements, flavoring additives, timing 
of purgative in relation to procedure time, medical 
management of side effects, and modified PEG 
purgative preparations [A-Rahim and Falchuk, 
2011]. While not approved by the Food and Drug 
Administration (FDA), MiraLAX-based bowel 
preparations (MBBP) have emerged as a popular 
bowel preparation choice due to their low volume 
and palatability [Enestvedt et al. 2011a]. MiraLAX 
is an osmotic laxative composed of PEG (average 
molecular weight 3350) without electrolytes that 
is FDA-approved for the treatment of constipa-
tion. This agent is available without prescription 
and has been prescribed ‘off label’ as a bowel 
preparation agent. Split dosing of the purgative, 
that is, the administration of a portion of the pur-
gative on the day of colonoscopy, has been 
consistently shown to improve bowel preparation 
quality [Abdul-Baki et al. 2008; Kilgore et al. 
2011; Marmo et al. 2010; Park et al. 2007, 2010]. 
With regard to precolonoscopy diet, several stud-
ies have examined the impact of alternative dietary 
recommendations (low-residue [Delegge and 
Kaplan, 2005; Rapier and Houston, 2006; Wu 
et al. 2011] or fiber-free diet [Soweid et al. 2010], 
light breakfast followed by clear liquids [Scott 
et al. 2005], and regular diet followed by clear 
liquids or low-residue meals [Aoun et al. 2005]) 
with a variety of purgative agents and found that 
bowel cleansing and patient tolerability were at 
least as good as with a clear liquid diet, if not 
better. The relative use of some of these newer 
methods among US physicians in clinical practice 
is unknown.
As part of a larger study to assess barriers to 
optimal bowel preparations [Clarke Hillyer et al. 
2012], we sought to examine the prevalence and 
patterns of utilization of three newer approaches 
to bowel preparation for colonoscopy among 
gastroenterologists in the US. Specifically, we 
examined use of liberalized diet, purgative split 
dosing, and MBBP to gain insight to the uptake 
of these newer methods.
Methods
A full description of the study methods can 
be found elsewhere [Clarke Hillyer et al. 
2012]. Briefly, a complete American College of 
Gastroenterology membership list was obtained 
(n = 10,228). Those with nonclinical affiliations 
(e.g. pharmaceutical companies) and credentials 
were excluded. As it was not feasible to survey all 
members, we chose to randomly select a 20% 
sample of physicians (MD or DO). The advantage 
of randomization was that it created a study group 
with a balanced and representative distribution of 
the factors under consideration while accounting, 
quantitatively, for potential confounders associ-
ated with alternative sample selection techniques 
[Rothman and Greenland, 2008]. Screening tele-
phone calls were placed to each practice and an 
additional 354 were excluded (deceased, n = 4; 
unable to locate, n = 33; retired, n = 27; and not a 
practicing gastroenterologist, only pediatric 
patients or other specialist that did not routinely 
perform screening colonoscopies, n = 290). To the 
999 eligible physicians, a Web-based or postal sur-
vey and an introductory letter of invitation was 
sent between September 2010 and March 2011. A 
small incentive was offered upon completion of 
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the survey. Approval of the Columbia University 
Institutional Review Board was granted.
Participants were queried about age, gender, race, 
country of medical school training, specialty, and 
board certification. Practice characteristics 
included geographic location, practice setting 
(urban, suburban, or rural) and type (private or 
hospital/university), teaching hospital affiliation, 
and number of colonoscopies performed per week 
(<10, 11–20, 21–30 and >30). Additional ques-
tions determined the use of liberal versus restric-
tive liquid diet, purgative split dosing, and MBBP 
and concomitant use of Gatorade®. Liberal diet 
was considered to be a recommendation that 
included any solid food in the 24-hour period 
prior to colonoscopy.
Univariate and bivariate analyses were conducted. 
Pearson’s Chi-square test was used to test asso-
ciations between those participants who did and 
did not recommend liberal diet, split dosing, 
MBBP, and demographic and practice character-
istics. Multivariate analysis was conducted using 
covariates with p value < 0.1. We performed anal-
yses using SAS version 9.2 (SAS Institute, Cary, 
NC).
Results
A total of 1355 physicians were invited to partici-
pate among whom 999 were eligible and sent a 
survey; 288 (28.8%) responded to the survey. 
Overall, the majority of respondents were male, 
white, US medical school graduates, and GI 
specialist/board certified. The median age was 
48 years.
Of the 269 physicians who responded to the die-
tary restriction questions, 15% (n = 41) indicated 
that they prescribe a liberalized diet that included 
any food in the 24-hour period preceding colo-
noscopy (Table 1). Compared with those who 
prefer to recommend a restrictive liquid diet, 
these physicians tended to be >48 years of age 
(17.3% versus 13.2%), white (17.5% versus 
9.0%), and have a board certification other than 
GI (20.5% versus 14.2%). Diet recommendations 
varied by geographic location with physicians in 
the Northeast section of the US twice as often 
and more than three times as often prescribing a 
liberalized diet compared with those in the South 
and West including Hawaii (25% versus 12.8% 
and 7.6%, respectively) and significantly more 
likely to recommend liberal diet compared with a 
more restrictive diet (p = 0.004). Physicians in the 
West were nearly three times as likely to recom-
mend restrictive diets (odds ratio [OR] 2.98, 95% 
confidence interval [CI] 1.16–7.67).
A total of 60% (170/283) of respondents stated 
that they recommend split dosing of the purgative 
to their patients (Table 1). These physicians more 
often graduated from US medical schools, were 
certified in gastroenterology, and performed more 
than 30 colonoscopies per week. In comparison 
with those who did not recommend split dose 
purgatives, those that did were more likely to be 
older (>48 years; 67.2% versus 53.2% for younger 
age, p = 0.018), in private versus hospital/univer-
sity practice types (63.8% versus 50.5%, p = 0.03), 
and affiliated with nonteaching hospitals (68.0% 
versus 55.1%, p = 0.034). After controlling for 
country where the physician attended medical 
school, type of practice (private versus university/
hospital), and teaching hospital affiliation, older 
age (>48 years) remained a strong predictor of 
use of split dosing (OR 1.76, 95% CI 
1.04–2.97).
More than one-third of respondents indicated 
that they prescribe MBBP (106/283) and of 
these, half practice in suburban settings (50.0% 
versus 38.9% in rural settings and 29.1% in urban 
settings, p = 0.003) (Table 1). Recommendation 
of MBBP was significantly more common among 
physicians in private practice than those in a hos-
pital or university-based setting (43.5% versus 
29.0%, p = 0.02). Furthermore, a positive linear 
association was observed with regard to the num-
ber of reported colonoscopies performed per 
week and the proportion of physicians using 
MBBP (p = 0.04) with physicians performing 
>30 colonoscopies per week more than twice as 
often recommending MBBP than those perform-
ing ≤10 per week. Only suburban practice (OR 
2.14, 95% CI 1.23–3.73), however, was signifi-
cant after controlling for other covariates. Of 
those who prescribed MBBP, 82.1% also recom-
mended Gatorade® (p <0.0001) (data not 
shown).
Of the 267 respondents who answered all three 
questions, we examined concurrent recommen-
dation of these newer approaches; 17.6% use 
none of these methods and 3.7% used all three 
(Table 2). Split dosing alone (36.0%) and with 
MBBP (15.7%) and MBBP alone (15.7%) were 
most commonly reported whereas liberal diet 
alone or in combination with split dose purgative 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































or MBBP (3.7%, 5.2%, and 2.2%) were the least 
frequently utilized methods.
Table 3 displays comparisons between the three 
approaches demonstrating that those who recom-
mended split dose purgative were less likely to use 
MBBP (32.5% versus 67.5%, p = 0.03). No sig-
nificant association between the recommendation 
of a liberal diet and use of split dosing or MBBP 
was found.
Discussion
Of the three newer approaches to bowel prepara-
tion examined (liberalized diet, split dose purgative 
and MBBP) among a random sample of members 
of the American College of Gastroenterologists, 
purgative split dosing is most commonly reported 
(60%), followed by MBBP (37%), and liberalized 
diet (15%). In our study, a surprisingly large num-
ber of physicians, particularly those in suburban 
locations and private practice, indicated that they 
recommend MBBP for their adult patients and 
over 80% combine MBBP use with Gatorade®. We 
also found that physicians in higher colonoscopy 
volume practices and those who were less likely to 
use split dosing were more likely to adopt this 
newer approach to bowel preparation.
Good quality preparation for colonoscopy is criti-
cal to an accurate and thorough examination of 
the bowel. Multiple variations to bowel prepara-
tion regimens have been explored with the pur-
pose of increasing patient compliance, improving 
quality, and addressing issues of safety, effective 
administration, and tolerability. The current 
study examined the self-reported utilization of 
Table 2. Self-reported use of combined approaches 
of liberal diet, split dosing, and MiraLAX-based bowel 
preparations (MBBP) (n = 267).
Regimen N %
None 47 17.6
Liberal diet only 10 3.7
Split dose only 96 36.0
MBBP only 42 15.7
Liberal diet and split 
dose
14 5.2
Liberal diet and 
MBBP
6 2.2
Split dose and MBBP 42 15.7
Liberal diet, split 
dose, and MBBP
10 3.7
Therapeutic Advances in Gastroenterology 6 (1)
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three newer approaches to bowel quality improve-
ment and demonstrated that recommendations 
for each vary by and are associated with physician 
and practice characteristics.
Although MBBP is not FDA-approved for preco-
lonoscopy bowel preparation, its efficacy and toler-
ability as a bowel cleansing agent in pediatric 
populations is well known [Adamiak et al. 2010; 
Pashankar et al. 2004; Safder et al. 2008], but 
reports among adults are mixed. Stratton and col-
leagues, in a letter to the editor of the American 
Journal of Gastroenterology, reported the efficacy, 
tolerability, safety, and compliance with PEG 3350 
(MBBP) among adults in their community clinic 
[Stratton et al. 2008]. Beyond this, the researchers 
stated that PEG 3350 has several advantages over 
other single-agent preparations that included easy 
accessibility to patients, as it is an over-the-counter 
formulation, lower cost, and a less-complicated 
regimen for patients to follow. Conversely, two 
randomized controlled studies of the bowel cleans-
ing efficacy of MBBP found that, compared with 
4 liters of PEG (GoLytely), MBBP was not as 
effective in bowel cleansing but that patients found 
the preparation experience to be at least as tolera-
ble/satisfactory as PEG [Enestvedt et al. 2011a; 
Hjelkrem et al. 2011]. Another study, a post hoc 
analysis of the adenoma detection rate of MBBP 
versus GoLytely, showed that MBBP produced 
fewer high-quality bowel preparations and a lower 
adenoma detection rate than GoLytely [Enestvedt 
et al. 2011b]. Our finding that use of MBBP 
increases with colonoscopy volume may indicate 
that in high-throughput practices and among those 
less likely to use split dosing, in spite of its failings, 
MBBP is gaining popularity which may be due to 
patient preference and tolerability over more tradi-
tional single-dose preparations.
That the majority of gastroenterologists recom-
mend splitting the purgative dose is not surprising 
since this method has been more intensively stud-
ied, has demonstrated efficacy [Abdul-Baki et al. 
2008; Aoun et al. 2005; El Sayed et al. 2003; 
Kilgore et al. 2011; Marmo et al. 2010; Park et al. 
2007, 2010], and is advocated in published guide-
lines [Rex et al. 2009; Wexner et al. 2006]. Our 
findings suggest that among those who split the 
purgative dose, strict adherence to liquid diet is a 
lesser issue, most likely because of the effective-
ness of split dosing in cleansing the bowel. We 
surmise that, for similar reasons, those who pre-
scribe split dosing were also less likely to recom-
mend MBBP. In our sample population, the 
majority of physicians who routinely recommend 
split dosing were the older physicians in private 
practice suggesting the adoption of bowel cleans-
ing strategies that are more amenable to their pri-
vate patients.
Interestingly, most research conducted on the use 
of split dosing has been conducted outside of the 
United States [Abdul-Baki et al. 2008; Aoun et al. 
2005; El Sayed et al. 2003; Frommer, 1997; 
Marmo et al. 2010; Park et al. 2007, 2010; Parra-
Blanco, 2006; Rostom et al. 2006]. A single US 
study by Matro and colleagues explored the effi-
cacy of split dose versus morning-only use of PEG 
finding that these two methods are equivalent 
with regard to quality of cleansing and polyp 
detection [Matro et al. 2010]. Another study of 
300 colonoscopy patients and their drivers dem-
onstrated that 85% of those surveyed would be 
willing to rise in the middle of the night to con-
sume a second dose of purgative, and of 
107 patients, 78% actually did comply with this 
protocol [Unger et al. 2010]. No others, however, 
have demonstrated that splitting the purgative 
Table 3. Comparison of diet versus split dose, diet versus MiraLAX-based bowel preparation MBBP, and split 
dose versus MBBP.
Diet Split dose
 Liberal Restricted p value Yes No p value
Split dose 0.91 –
 Yes 24 (60.0) 139 (61.0) – –  
 No 16 (40.0) 89 (39.0) – –  
MBBP 0.81 0.03
 Yes 16 (39.0) 84 (37.0) 55 (32.5) 51 (45.1)  
 No 25 (61.0) 143 (63.0) 114 (67.5) 62 (54.9)  
Note: Diet versus split dose, n = 268; diet versus MBBP, n = 268; and split dose versus MBBP, n = 282.
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dose (AM/PM) compared with ingestion on the 
day prior to the procedure can be successfully 
implemented among American hospital outpa-
tients. Our findings support the existence of bar-
riers to the more complete implementation of this 
procedure among younger US physicians in hos-
pital/university and teaching settings where rates 
of suboptimal bowel preparation is more com-
monly encountered.
Despite the lack of rigorous evidence for the supe-
riority of a clear liquid diet, many gastroenterolo-
gists continue to recommend this stringent diet 
during the 24-hour period preceding a colonos-
copy, but this recommendation is by no means 
uniform. Clear liquid-only diet is recommended 
in review articles on this subject and in the con-
sensus statement on bowel preparation prior to 
colonoscopy offered by the task force including 
the American Society of Gastrointestinal 
Endoscopy and the American Society of Colon 
and Rectal Surgeons [A-Rahim and Falchuk, 
2011; Wexner et al. 2006]. Studies of precolonos-
copy diet, however, show that the efficacy of 
cleansing is comparable for clear liquid diet and 
other diets that include any food, whether low 
residue [Delegge and Kaplan, 2005; Rapier and 
Houston, 2006; Wu et al. 2011], fiber-free 
[Soweid et al. 2010], or regular [Aoun et al. 2005; 
Scott et al. 2005]. Of the physicians in this study 
that do recommend a liberal diet, respondents in 
the Northeastern US were twice as likely as physi-
cians in the South and more than three times as 
likely as physicians in the West, including Hawaii, 
to use this approach.
Choice of diet has been shown to enhance tolerabil-
ity of the purgative [Rapier and Houston 2006; 
Soweid et al. 2010] and may influence compliance 
with the prescribed purgative. While data regarding 
the impact of diet on the quality of experience from 
the patient’s perspective are sparse, bowel prepara-
tion remains the most unpleasant aspect of colo-
noscopy [Ko et al. 2007] and a diet that is more 
lenient than that of clear liquids only is rated more 
favorably [Delegge and Kaplan, 2005]. In the con-
text of a procedure that is performed on more than 
14 million individuals annually in the United States 
[Seeff et al. 2004], seemingly minor changes in die-
tary recommendations may have a substantial pub-
lic health impact on purgative compliance. A more 
palatable precolonoscopy experience may increase 
screening rates and discourage ‘cheating’ on the 
preprocedure bowel preparation, resulting in 
higher-quality colonoscopic examinations and a 
greater aggregate impact on cancer incidence and 
mortality.
This study has its limitations. The response rate 
was 28.8% and is comparable to, if not better 
than, other studies of the membership of the 
American College of Gastroenterologists [Cattau, 
2010; Cohen et al. 2006; Sorbi et al. 2003; Spergel 
et al. 2011; Trindade et al. 2011; Wasan et al. 
2011]. Response rates in these studies ranged 
from 5.8% to 32.7% and covered topics such as 
medication adherence among patients with 
inflammatory bowel disease [Trindade et al. 
2011], management of variceal bleeding [Sorbi et 
al. 2003], and current practices in endoscopy and 
sedation [Cohen et al. 2006]. For whatever rea-
son, whether continual bombardment with 
requests for survey participation, lack of interest 
in the topic, lack of time, or lack of proper incen-
tives, response rate among this group has been 
repeatedly demonstrated to be low. By compari-
son, our rate of response is consistent with that of 
others. In addition, our study relied on self-report 
of behaviors and may not reflect the complex 
judgment process involved in individual recom-
mendations for bowel preparation regimens.
Conclusions
While the literature on MBBP is limited and sug-
gests that these regimens are not as effective as 
FDA-approved bowel preparation regimens 
[Enestvedt et al. 2011a, 2011b; Hjelkrem et al. 
2011], our results indicate that a large proportion 
of gastroenterologists throughout the US pre-
scribe MBBP. With this practice becoming more 
popular among high-volume gastroenterologists, 
an even higher proportion of patients in the US 
are being offered MBBP. Further studies regard-
ing safety, efficacy, and optimal dosing data of 
MBBP are needed given the apparent popularity 
of these regimens. As split dosing is considered to 
be a key measure to improve the quality and cost-
effectiveness of colonoscopy, that so many rou-
tinely use this method is encouraging. Because 
patient populations in hospital/university and 
teaching settings most likely differ dramatically 
from private practice in terms of demographic and 
socioeconomic characteristics, further investiga-
tion of the acceptability and desirability of this 
procedure among certain American populations is 
warranted. Continuing medical education to 
increase uptake of the split dose purgative method 
is indicated as well as evaluation of barriers to use 
in nonprivate practice settings. Lastly, although 
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the use of a more liberalized diet is becoming more 
popular in the Northeast, it is far from becoming 
an accepted practice. Additional research on the 
importance of dietary restriction in the context of 
better purgative compliance may lead to less strin-
gent dietary requirements in the future and more 
widespread acceptance of this approach.
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